Gary Steinberg
@garysteinbergmd
Followers
1K
Following
1K
Media
6
Statuses
151
Professor of Urology Rush Univ, immediate past Chairperson Scientific Advisory Board of BCAN. Specialize in novel bladder cancer treatments, surgery, trials
2215 N Halsted ST, Chicago, Il
Joined August 2019
https://t.co/wsYaGPzIH0 Recent review re: CREST TRIAL HR BCG NAIVE NMIBC #gdsfellows @RushUrology @RushCancer @UroDocAsh #bladdercancer
0
2
15
NYC is great but very glad to be back sweet home Chicago! I start at Rush July 10th in the cancer center and dept of Urology #gdsfellows #bladdercancer @bcan
3
0
70
Lots of discussion after recent SUO match .. Should Research Year be optional for SUO accredited fellowships ?
3
7
14
Intermediate risk #NMIBC: Surveillance and treatment challenges. #AUA23 debate moderated by @SWilliams_MD along with @paolo_gontero and @garysteinbergmd. Written coverage by @zklaassen_md @GACancerCenter > https://t.co/ny0wFzQFqz
@AmerUrological
0
5
19
Updated results from #CORE1 using pembro + cretostimogene (cg0070) in BCG unresponsive CIS 👉 Overall CR = 85% (29/34) 👉CR @ 12 months = 68% (17/25) 👉AE profile similar to monotherapy trials @garysteinbergmd @UroDocAsh @tbivala1 @cgoncology
https://t.co/9jvfxWkzcs
onclive.com
Cretostimogene grenadenorepvec in combination with pembrolizumab produced high complete response rates with a tolerable safety profile in patients with Bacillus Calmette-Guérin–unresponsive non–mus...
4
14
59
In this exclusive video, @garysteinbergmd, from the Department of #Urology at @Perlmutter_CC, discusses multiple studies on therapies for non-muscle-invasive #bladdercancer and their implications for clinical practice. https://t.co/GLa0olU0PV
medpagetoday.com
Gary Steinberg, MD, discusses key abstracts from the Genitourinary Cancers Symposium
1
1
5
Targeting bladder cancer with precision immunotherapy vaccine may preserve the bladder https://t.co/bw251fWdUy
#gdsfellows @bcan_chisolm @NYUUrology @Perlmutter_CC @EdwardCherullo
lnkd.in
This link will take you to a page that’s not on LinkedIn
1
2
10
https://t.co/v1sV12Z1iN$ Neobladder for bladder cancer patients is successful Need to strive for innovative improvements #gdsfellows @bcan_chisolm @NYUUrology @Perlmutter_CC
0
2
6
0
2
9
0
0
5
Still many unresolved issues NMIBC Multiple studies ongoing with novel agents We need to choose a few lanes to make progress #gdsfellows @UroDocAsh @Perlmutter_CC @NYUUrology @bbmdmsk @BCAN_NCT
1
2
25
Neoantigen Cancer Vaccines Precision ImmunoOncologyReview #gdsfellows @Perlmutter_CC @NYUUrology @BCAN_NCT
https://t.co/nCf8rpCzIA
1
1
4
Watching The Tourist HBOmax Lead detective depicted easily emptying his ileal conduit never saw that in Drama before cystectomy IC patients live fully active lives #gdsfellows #bladdercancer @BCAN_NCT @Perlmutter_CC @NYUUrology
0
3
23
In significant number of patients ileal conduit performed well is the best option, patient selection for continent diversion is critical @NYUUrology #gdsfellows #bladdercancer @BCAN_NCT @siadaneshmand @UroDocAsh
2
3
48
Bladder Cancer landscape rapidly changing for the benefit of our patients #gdsfellows @NYUUrology @nyulangone @BladderCancerUS
medpagetoday.com
For those who are candidates, data are lacking on how to choose between available options
1
5
20
Great sessions FDA workshop Option 3 clinical trial design for novel agents in HR BCG naive is critical for innovation biotech and big pharma can accrue to these trials quickly and move on from BCG #gdsfellows @UroDocAsh @tbivala1 @BCAN_NCT @NYUUrology
0
4
22
SeaGen EV-104 intravesical Enfortumab Vedotin for HR NMIBC NYULangone First site now open Great potential treatment with novel MOA #gdsfellows @NYUUrology @BCAN_NCT @UroDocAsh
2
8
35
A fun debate with @JimCatto @UroDocAsh let’s work to improve TURBT and clinical staging Imaging We are way behind prostate @PhotocureASA @BCANY1 #gdsfellows #bladdercancer @NYUUrology
0
1
16